Literature DB >> 8761452

Compartment-specific regulation of phosphoinositide 3-kinase by platelet-derived growth factor and insulin in 3T3-L1 adipocytes.

B T Navé1, R J Haigh, A C Hayward, K Siddle, P R Shepherd.   

Abstract

To understand how the stimulation of phosphoinositide 3-kinase (PI 3-kinase) by different growth factors can activate different subsets of downstream responses, growth-factor regulation of PI 3-kinase activity at different intracellular locations was investigated in 3T3-L1 adipocytes. Insulin caused a large stimulation of glucose transport and stimulated recruitment of transferrin receptors to the plasma membrane (PM) in these cells, whereas platelet-derived growth factor (PDGF)-bb was virtually without effect on these responses. Subcellular fractionation studies after stimulation with PDGF-bb or insulin revealed a differential effect of these growth factors on subcellular localization of PI 3-kinase activity. PDGF was more effective than insulin in stimulating PI 3-kinase activity and recruiting the p85 alpha PI 3-kinase adaptor subunit in the fraction containing the PM. However, in the microsomal fraction insulin significantly increased PI 3-kinase activity and p85 alpha levels, whereas PDGF was almost without effect. In the microsomal membrane fraction the insulin-stimulated recruitment of p85 alpha closely matched the increase PI 3-kinase activity, indicating that insulin stimulation of PI 3-kinase in this fraction is largely due to recruitment of PI 3-kinase enzyme rather than alterations in specific activity. Insulin-stimulated recruitment of p85 alpha to the microsomal membranes was not inhibited by wortmannin, indicating that PI 3-kinase activity was not required for this process. A further level of compartment-specific regulation of PI 3-kinase in response to PDGF was revealed by the finding that tyrosine phosphorylation of the p85 alpha adaptor was restricted to the PM-containing fraction. Insulin had no effect on p85 tyrosine phosphorylation in either fraction. In summary, these results suggest a basis by which insulin and PDGF could both use PI 3-kinase signalling cascades but achieve different signalling outcomes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8761452      PMCID: PMC1217588          DOI: 10.1042/bj3180055

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Requirement for phosphoinositide 3-kinase in insulin-stimulated GLUT4 translocation in 3T3-L1 adipocytes.

Authors:  K Kotani; A J Carozzi; H Sakaue; K Hara; L J Robinson; S F Clark; K Yonezawa; D E James; M Kasuga
Journal:  Biochem Biophys Res Commun       Date:  1995-04-06       Impact factor: 3.575

2.  Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling.

Authors:  S Wennström; P Hawkins; F Cooke; K Hara; K Yonezawa; M Kasuga; T Jackson; L Claesson-Welsh; L Stephens
Journal:  Curr Biol       Date:  1994-05-01       Impact factor: 10.834

Review 3.  Receptor protein-tyrosine kinases and their signal transduction pathways.

Authors:  P van der Geer; T Hunter; R A Lindberg
Journal:  Annu Rev Cell Biol       Date:  1994

4.  1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells.

Authors:  K Hara; K Yonezawa; H Sakaue; A Ando; K Kotani; T Kitamura; Y Kitamura; H Ueda; L Stephens; T R Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

5.  Characterization of a phosphatidylinositol-specific phosphoinositide 3-kinase from mammalian cells.

Authors:  L Stephens; F T Cooke; R Walters; T Jackson; S Volinia; I Gout; M D Waterfield; P T Hawkins
Journal:  Curr Biol       Date:  1994-03-01       Impact factor: 10.834

6.  Activation of mitogen-activated protein kinase and phosphatidylinositol 3'-kinase is not sufficient for the hormonal stimulation of glucose uptake, lipogenesis, or glycogen synthesis in 3T3-L1 adipocytes.

Authors:  R J Wiese; C C Mastick; D F Lazar; A R Saltiel
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

7.  The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf.

Authors:  D A Cross; D R Alessi; J R Vandenheede; H E McDowell; H S Hundal; P Cohen
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

8.  Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase.

Authors:  P R Shepherd; B T Navé; K Siddle
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

9.  Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin.

Authors:  J F Clarke; P W Young; K Yonezawa; M Kasuga; G D Holman
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

10.  Inhibitors of phosphoinositide 3-kinase block exocytosis but not endocytosis of transferrin receptors in 3T3-L1 adipocytes.

Authors:  P R Shepherd; M A Soos; K Siddle
Journal:  Biochem Biophys Res Commun       Date:  1995-06-15       Impact factor: 3.575

View more
  33 in total

1.  Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases.

Authors:  C A Beeton; E M Chance; L C Foukas; P R Shepherd
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

2.  Oxidative stress impairs insulin but not platelet-derived growth factor signalling in 3T3-L1 adipocytes.

Authors:  A Tirosh; A Rudich; R Potashnik; N Bashan
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

3.  Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.

Authors:  A Takano; I Usui; T Haruta; J Kawahara; T Uno; M Iwata; M Kobayashi
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

4.  Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1.

Authors:  Rachel Zhande; John J Mitchell; Jiong Wu; Xiao Jian Sun
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

5.  GLUT4 vesicle dynamics in living 3T3 L1 adipocytes visualized with green-fluorescent protein.

Authors:  P B Oatey; D H Van Weering; S P Dobson; G W Gould; J M Tavaré
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

6.  Rapid activation of sodium-proton exchange and extracellular signal-regulated protein kinase in fibroblasts by G protein-coupled 5-HT1A receptor involves distinct signalling cascades.

Authors:  M N Garnovskaya; Y Mukhin; J R Raymond
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

7.  Differential effects of constitutively active phosphatidylinositol 3-kinase on glucose transport, glycogen synthase activity, and DNA synthesis in 3T3-L1 adipocytes.

Authors:  E U Frevert; B B Kahn
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

Review 8.  Insulin signaling.

Authors:  M L Goalstone; B Draznin
Journal:  West J Med       Date:  1997-09

9.  Decreased insulin-dependent glucose transport by chronic ethanol feeding is associated with dysregulation of the Cbl/TC10 pathway in rat adipocytes.

Authors:  Becky M Sebastian; Laura E Nagy
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-08-16       Impact factor: 4.310

10.  Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth.

Authors:  A McGarry Houghton; Danuta M Rzymkiewicz; Hongbin Ji; Alyssa D Gregory; Eduardo E Egea; Heather E Metz; Donna B Stolz; Stephanie R Land; Luiz A Marconcini; Corrine R Kliment; Kimberly M Jenkins; Keith A Beaulieu; Majd Mouded; Stuart J Frank; Kwok K Wong; Steven D Shapiro
Journal:  Nat Med       Date:  2010-01-17       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.